Profhilo
Profhilo Body for abdominal skin laxity: what can the evidence support?
A small uncontrolled study reported changes in abdominal skin measurements after two sessions, but Profhilo Body cannot remove fat, repair separated muscles or replace surgery for substantial excess skin.
First identify what is causing the concern
An abdomen can look or feel different because of skin laxity, subcutaneous fat, bloating, scarring, muscle separation after pregnancy, a hernia or several factors together. Profhilo Body is a hyaluronic-acid injectable intended to address selected skin-quality concerns. It does not remove fat, strengthen the abdominal wall or repair a structural defect.
That distinction is important because loose surface skin may resemble deeper abdominal-wall weakness. A persistent central gap after pregnancy may need physiotherapy assessment, while a lump that changes with coughing or standing may be a hernia. Injecting the overlying skin would not treat either condition and could delay appropriate advice.
What did the abdominal study involve?
A single-centre study enrolled 24 healthy women aged 40 to 65 with mild-to-moderate roughness and laxity of the abdomen and inner arms. Participants received two treatment sessions one month apart. Researchers assessed photographs, clinical laxity scores, hydration, density and elastic behaviour at baseline, one month and four months.
The published report described improvement after the first session that was maintained at the final visit, with positive participant ratings and good tolerability. These findings suggest that selected skin measurements may change over a few months, but they do not show that treatment tightens the abdominal wall or produces a dramatic visible transformation.
Why the evidence remains uncertain
The study had no untreated, placebo or alternative-treatment comparison group, and everyone knew that treatment had been given. Normal variation, expectations, changes in skincare and measurement effects therefore cannot be separated confidently from the product. Only 24 women from one centre were included, and follow-up ended four months after the first session.
The study authors included employees of the manufacturer. A 2026 systematic review identified nine Profhilo or Profhilo Body studies involving 278 participants across several facial and body areas, but some review authors also worked for the manufacturer. Different areas, schedules and measurements were combined, so the review does not establish how much visible abdominal improvement an individual should expect or how long it will last.
What Profhilo Body cannot be expected to do
Improved hydration, roughness or elasticity is not the same as reducing weight, flattening the abdomen or removing an overhang of skin. The treatment should not be presented as an alternative to nutrition, exercise, physiotherapy, weight-management support or surgery when those options address the actual concern. Severe laxity was not studied.
The NHS explains that abdominal muscle separation after pregnancy often improves, but a persistent obvious gap can be assessed by a GP and may benefit from physiotherapy. A suspected hernia also needs medical assessment. Pain, vomiting, bloating, constipation, fever or a painful lump requires urgent advice rather than a cosmetic procedure.
Downtime and possible adverse effects
Expected short-term effects include stinging, tenderness, redness, swelling, itching, small raised injection points, pinpoint bleeding or bruising. The abdomen may feel sore with clothing, exercise or pressure for a short period. Published studies are too small to identify uncommon complications reliably, so treatment should never be described as risk-free.
Increasing pain, spreading redness or heat, discharge, fever, marked or persistent swelling, unusual pale or mottled skin, numbness or a worsening abdominal lump needs prompt clinical assessment. Sterile technique, appropriate product storage, clear written aftercare and access to a trained clinician are important for any injectable procedure.
Suitability must be assessed in person
Consultation should review the main concern, weight stability, pregnancy and childbirth history, previous abdominal surgery, scars, hernia or muscle separation, skin disease, medical conditions, medicines, allergies, pregnancy or breastfeeding and prior procedures. Active infection, dermatitis, an unhealed wound or an unexplained lump may mean postponing treatment or seeking medical review.
A proportionate discussion should cover the limited evidence, likely subtle result, alternatives, treatment burden, downtime, total cost and follow-up. GMC guidance requires honest explanation of risks and lower-risk options. Choosing not to proceed is appropriate when the concern is structural, expectations exceed what skin-quality treatment can achieve or suitability is uncertain.
Research and further reading
- 2022 single-centre study of Profhilo Body for inner-arm and abdominal laxity ↗
- Registered study protocol for abdominal and inner-arm skin roughness and laxity ↗
- 2026 systematic review of Profhilo and Profhilo Body studies ↗
- NHS guidance on post-pregnancy abdominal muscle separation ↗
- NHS guidance on abdominal hernia symptoms and urgent advice ↗
- GMC guidance on risks, alternatives and follow-up for cosmetic interventions ↗